医疗技术和疗法开发商RBL获得融资，以支持其推出突破性初创公司并将其扩展为临床阶段公司的使命-动脉网

RBL LLC secures investment from Modi Ventures

CISION 等信源发布 2025-08-08 19:00



可切换为仅中文







Strategic investment to support RBL's mission to launch and scale breakthrough startups

战略性投资以支持RBL推出和扩展突破性初创企业的使命

Founder and general partner of Modi Ventures,

模迪创投的创始人兼普通合伙人，

Sahir Ali

萨希尔·阿里

, to join RBL board of directors

，加入RBL董事会

Modi Ventures' Ali, RBL managing partner Wotton to speak on venture creation at Canaccord Genuity Growth Conference

Modi Ventures的阿里和RBL管理合伙人沃顿将在Canaccord Genuity成长大会上就风险投资创建发表演讲

Aug. 12

8月12日

HOUSTON

休斯顿

，

Aug. 8, 2025

2025年8月8日

/PRNewswire/ --

RBL LLC

RBL有限责任公司

, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies, announced that it has secured an investment from

，一家致力于基于突破性医疗技术快速创建公司的先锋生物技术风险创造工作室，宣布已获得来自

Modi Ventures

莫迪创投

to support its mission to launch and scale breakthrough startups into clinical-stage companies.

支持其将突破性初创公司发展为临床阶段公司的使命。

In addition, RBL has announced the appointment of

此外，RBL宣布了任命

Sahir Ali

萨希尔·阿里

to its board of directors. Ali is the founder and current general partner of Modi Ventures, a leading venture capital firm investing in biology and technology based in

加入其董事会。阿里是莫迪创投的创始人兼现任普通合伙人，这是一家领先的生物和技术领域的风险投资公司，总部位于

Houston

休斯顿

. Ali's experience as an accomplished technology and health care leader, investor and adviser will be instrumental in bridging the gap between academic biotech discoveries and the clinical care market.

阿里作为一位杰出的技术和医疗保健领导者、投资者和顾问的经验，将在弥合学术生物技术发现与临床护理市场之间的差距方面发挥关键作用。

'This investment by Modi Ventures will be instrumental to RBL's growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,' said

莫迪风险投资公司的这笔投资将对RBL的成长起到重要作用，因为它增强了对我们创业模式的信心，并加速了我们开发成功的生物技术初创公司的能力。

Paul Wotton

保罗·沃顿

, RBL's managing partner. 'Sahir's addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.'

，RBL的管理合伙人。‘Sahir加入董事会也将加强与Modi的合作。他富有战略性的建议和对领域定义技术的深刻理解将是我们持续成长并实现使命的无价之宝。’

'The bold thinking and entrepreneurial initiatives coming out of RBL represent an important cornerstone of the rapidly evolving

“RBL提出的富有远见的思维和创业举措代表了快速发展的

Houston

休斯顿

life sciences scene, and I am honored to contribute to this growth by joining this exceptional board,' Ali said. 'Partnering my new role at RBL with the investment made by Modi can truly help not only build companies but also shape the future of patient care in a collaborative and more efficient way.'.

阿里说：“生命科学领域，我很荣幸能够加入这个杰出的董事会，为这一增长做出贡献。将我在RBL的新角色与莫迪的投资合作，不仅可以帮助建立公司，还能以协作和更高效的方式塑造患者护理的未来。”

'Modi Ventures' investment is a strong signal of market validation for the acceleration model we've built into RBL,' said

“莫迪风险投资公司的投资对我们融入RBL的加速模型来说，是市场认可的一个强烈信号，”他说道

Paul Cherukuri

保罗·切鲁考里

, board member of RBL and chief innovation officer of

，RBL董事会成员及首席创新官

Rice University

莱斯大学

. 'It reflects growing investor confidence in RBL's ability to turn breakthrough science into real-world therapies and in

它反映了投资者对RBL将突破性科学转化为现实疗法能力的信心日益增强，以及对

Houston's

休斯顿的

rise as a global force in biotech innovation.'

崛起为生物技术创新的全球力量。

Modi Ventures employs a proprietary financial engineering framework grounded in modern portfolio theory and efficient frontier principles. With

莫迪创投采用基于现代投资组合理论和有效前沿原则的专有金融工程框架。通过

$134 million

1.34亿美元

under management, Modi Ventures backs category-defining companies advancing artificial intelligence (AI)-driven drug discovery, diagnostics and engineered therapeutics. The firm also invests in leading funds across the biotech and technology spectrum. A parallel entrepreneur, scientist and innovator, Sahir has led transformative work and built companies across AI, cloud computing and precision medicine. Sahir serves on the board of directors of the Drug Information Association, a leading global life science membership association driving collaboration in drug, device and diagnostics development in pursuit of a healthier world..

在管理之下，Modi Ventures 支持推动人工智能（AI）驱动的药物发现、诊断和工程治疗的定义类别的公司。该公司还投资于生物科技和技术领域的领先基金。作为一名平行创业者、科学家和创新者，Sahir 在人工智能、云计算和精准医疗领域领导了变革性工作并创立了多家公司。Sahir 还担任药物信息协会的董事会成员，该协会是一个领先的全球生命科学会员组织，致力于推动药物、设备和诊断开发方面的合作，追求更健康的世界。

Sahir will join existing board members Wotton, Cherukuri,

萨希尔将与现有的董事会成员沃顿、切鲁库里一起加入。

Omid Veiseh

奥米德·维赛

，

Rima Chakrabarti

里玛·查克拉巴蒂

，

John Jaggers

约翰·贾格斯

，

Devyn Smith

德文·史密斯

and

和

James Watson

詹姆斯·沃森

, an accomplished group of leaders with deep expertise in biotech innovation, clinical translation and venture building who together provide strategic guidance to help drive RBL's continued growth and success.

，一群在生物技术创新、临床转化和风险建设方面具有深厚专业知识的杰出领导者，他们共同提供战略指导，以推动RBL的持续增长和成功。

Wotton and Ali will participate in a panel discussion at the

沃顿和阿里将参加一个小组讨论。

Canaccord Genuity 45

加拿大丰业银行 45

nnual Growth Conference

年度增长会议

Aug. 12

8月12日

to discuss the future of biotech venture creation and the evolving role of academic innovation in company formation.

讨论生物技术风险投资创建的未来以及学术创新在公司组建中不断演变的角色。

About RBL LLC:

关于RBL有限责任公司：

RBL LLC is a pioneering biotech venture creation studio based in

RBL有限责任公司是一家位于

Houston

休斯顿

that is dedicated to accelerating the development of breakthrough medical technologies and therapies through company formation. RBL provides entrepreneurs, researchers and innovators with infrastructure, financial support and strategic guidance as well as access to laboratory space and shared resources in the Texas Medical Center Helix Park.

该机构致力于通过公司组建来加速突破性医疗技术和疗法的开发。RBL为企业家、研究人员和创新者提供基础设施、财政支持和战略指导，以及在德克萨斯医学中心螺旋公园内的实验室空间和共享资源的访问权限。

For more information, please visit .

欲了解更多信息，请访问。

https://www.rbl-llc.com/

。

Media Contact:

媒体联系人:

Russo Partners

鲁索合伙人

David Schull

大卫·舒尔

或